2020
DOI: 10.1002/fsn3.1637
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced oral bioavailability and bioefficacy of phloretin using mixed polymeric modified self‐nanoemulsions

Abstract: Phloretin (Ph) is a natural active ingredient with wide biological properties. However, its poor water‐solubility and low oral bioavailability limit the application significantly in functional food and drug. This study was to explore the mixed polymer Pluronic® F127 and P123 modified the different triglycerides (LCT, MCT, SCT) in self‐nanoemulsions (SNEs) for enhancing the oral bioavailability and bioefficacy of Ph. The SNEs were characterized in terms of physical property study, lipolysis study, pharmacokinet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 31 publications
0
11
0
Order By: Relevance
“…Phlorizin was the first natural SGLT1/2 inhibitor discovered [ 8 ]. Despite its benefits improving insulin resistance [ 1 ] and diabetic complications such as nephropathy [ 23 ], non-alcoholic fatty liver disease [ 29 ], diabetic cardiomyopathy [ 35 ], or endothelial dysfunction [ 34 ], phlorizin had several drawbacks as a therapeutic agent, which included: (1) low oral bioavailability [ 60 ], (2) poor intestinal absorption and rapid clearance in urine [ 60 ], (3) low stability, being metabolized to phloretin in the small intestine by β-glucosidases [ 9 ], which inhibits GLUT1 [ 61 ] (responsible for glucose uptake in many tissues including the brain [ 62 ]), and (4) low solubility in water [ 63 ]. All of these observations, and the fact that mutations in the SGLT1 gene are associated with intestinal glucose–galactose malabsorption and associated fatal diarrhea [ 38 , 64 ], and that osmotic water flow through SGLT1 is blocked by phlorizin [ 65 ], prevented phlorizin from its use as an anti-diabetic drug.…”
Section: Sglt2 Inhibitorsmentioning
confidence: 99%
“…Phlorizin was the first natural SGLT1/2 inhibitor discovered [ 8 ]. Despite its benefits improving insulin resistance [ 1 ] and diabetic complications such as nephropathy [ 23 ], non-alcoholic fatty liver disease [ 29 ], diabetic cardiomyopathy [ 35 ], or endothelial dysfunction [ 34 ], phlorizin had several drawbacks as a therapeutic agent, which included: (1) low oral bioavailability [ 60 ], (2) poor intestinal absorption and rapid clearance in urine [ 60 ], (3) low stability, being metabolized to phloretin in the small intestine by β-glucosidases [ 9 ], which inhibits GLUT1 [ 61 ] (responsible for glucose uptake in many tissues including the brain [ 62 ]), and (4) low solubility in water [ 63 ]. All of these observations, and the fact that mutations in the SGLT1 gene are associated with intestinal glucose–galactose malabsorption and associated fatal diarrhea [ 38 , 64 ], and that osmotic water flow through SGLT1 is blocked by phlorizin [ 65 ], prevented phlorizin from its use as an anti-diabetic drug.…”
Section: Sglt2 Inhibitorsmentioning
confidence: 99%
“…However, plastic waste is on the rise and is likely to reach more than 12,000 million metric tons by 2050 (Geyer et al., 2017 ). Therefore, the food packaging industry is trying to reduce the consumption of plastic polymers and replace them with renewable and natural biopolymers obtained from different sources (Wang et al., 2020 ; Zemljič et al., 2020 ). Various biopolymers such as lipids, polysaccharides, and proteins have been used for packaging purposes (Ekramian et al., 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…The yield of the main glycoside in each reaction relative to the initial acceptor concentration was also calculated from the HPLC chromatograms, achieving the highest values with hydroquinone (26.0%), gallic acid (21.7%), and rosmarinic acid (two major peaks of 20.9% and 20.0%, which represents a 40.9% acceptor conversion) (Table 3). However, it must be noted that in the case of phloretin and pterostilbene, some precipitation of the acceptor molecules was observed during the reactions due to their low solubility under the conditions tested [50,51], which could have caused an underestimation of glycoside yields. These results confirm that rXynSOS-E236G glycosynthase is a promising tool to glycosylate a broad range of phenolic compounds with biotechnological applications.…”
Section: Glycosidementioning
confidence: 97%